KEGG   DRUG: Insulin injection, biphasic isophaneHelp
Entry
D08080                      Drug                                   

Name
Insulin injection, biphasic isophane (BAN);
Insulin Humacart (TN)
Class
Antidiabetic agent
 DG01636  Insulin and analogue
  DG01802  Human insulin
Cyp inducer
 DG01637  CYP1A2 inducer
Activity
Antidiabetic, Insulin with both rapid and intermediate action
Target
insulin receptor [HSA:3643] [KO:K04527]
  Pathway
Adherens junction
Insulin signaling pathway
Type II diabetes mellitus
Aldosterone-regulated sodium reabsorption
Interaction
CYP induction: CYP1A2 [HSA:1544]
Drug interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Receptor tyrosine kinase
   RTK class II (Insulin receptor family)
    insulin receptor
     Isophane insulin
      D08080  Insulin injection, biphasic isophane (BAN)
Cytochrome P450 interactions [BR:br08309]
 CYP inducers
  CYP1A2
   Insulin
    D08080  Insulin injection, biphasic isophane (BAN)
BRITE hierarchy
Other DBs
CAS: 
8063-29-4
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system